All in the Genes
By Marcy Darnovsky and Hank Greely,
Democracy
| 08. 31. 2008
Henry Greely inaccurately characterizes my organization, the Center for Genetics and Society, as "drawn to arguments against [inheritable human genetic enhancement] by the lure of naturalness" ["The Genetics of Fear," Issue #9].
I am not sure how Greely reached this conclusion. We explicitly ground our opposition in our commitments to social justice and equality. Procedures that produce (or claim to produce) genetically superior children for those with access to expensive technologies would all too likely exacerbate inequalities and lead to new forms of discrimination.
Greely seems enthusiastic about inheritable genetic modification, but he also recognizes that significant improvements are a long way off. He therefore dismisses proposals, such as the one offered by Jamie Metzl, for international agreements to prohibit socially undesirable human biotechnologies ["Brave New World War," Issue #8]. He disparages efforts at international regulation as "neither progressive nor wise," without mentioning that similar regulations are already in effect, and working well, in over four dozen countries. The United States should join this growing international consensus.
Greely warns ominously that regulating biotechnology "would almost certainly...
Related Articles
By staff, Japan Times | 12.04.2025
Japan plans to introduce a ban with penalties on implanting a genome-edited fertilized human egg into the womb of a human or another animal amid concerns over "designer babies."
A government expert panel broadly approved a proposal, including the ban...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
By Tina Stevens, CounterPunch | 12.11.2025
Silicon Valley and other high tech billionaires are investing millions in start-ups dedicated to creating genetically engineered (GE) babies, according to a recent Wall Street Journal (WSJ) report. AI mogul Sam Altman, cryptocurrency entrepreneur Brian Armstrong, venture capitalist Peter...
By Jenny Lange, BioNews | 12.01.2025
A UK toddler with a rare genetic condition was the first person to receive a new gene therapy that appears to halt disease progression.
Oliver, now three years old, has Hunter syndrome, an inherited genetic disorder that leads to physical...